FDA Panel Narrowly Backs DNA Colon Cancer Test

FDA Panel Narrowly Backs DNA Colon Cancer Test

A panel of Food and Drug Administration advisers has narrowly backed an experimental blood test that uses patients' DNA to help screen for colon cancer. The FDA's genetic experts voted 5-4, with one abstention, that the benefits of Epigenomics' test …

4
Like
Save

Comments

Write a comment

*